EventInvest
Sign in
Brooks LaboratoriesBROOKS

Brooks Laboratories: Demerger

Brooks Laboratories is demerging a business into Abridge Speciality Limited.

Next dateNo date has been stated yet.Stage 1 of 7: Board approval

Terms

Each figure links to its source
Entitlement
1 share of Abridge Speciality Limited for every 1 share of Brooks Laboratories
Record date
Not known: Not yet stated in a filing
Resulting company lists
Not known: Not yet stated in a filing
Resulting company
Abridge Speciality Limited
Stock exchanges (observation letter): pendingShareholders and creditors: pendingNational Company Law Tribunal: pending

Timeline

12 steps
  1. Board approval14 Oct 2026
  2. Draft scheme filed with the exchangesDate not yet stated
  3. Exchange observation letterDate not yet stated

9 more steps, each with its date and filing. Free with a Google sign-in.

Sign in with Google

Source documents

1 filing

1 filing from the exchanges and SEBI, with links. Free with a Google sign-in.

Sign in with Google

What this means for a shareholder

In a demerger a business is moved out of a listed company into a separate company, and the listed company’s shareholders receive shares of it in a stated ratio. The scheme follows the same approvals as a merger: exchanges, shareholders and creditors, and the NCLT.

Shares of the resulting company are credited after the record date and trade only once the exchanges list them, which can take weeks.

How demergers work, step by step →

Updated 20:44 IST · Information from public filings. Not investment advice.